Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Winsunny Pharmaceutical is a prominent Chinese pharmaceutical company focused on the development and manufacturing of chemical drugs, particularly for chronic disease management. As a core subsidiary of China Resources Double-Crane Pharmaceutical, the company specializes in therapeutic areas including cardiovascular health, endocrinology, and nephrology. Its extensive product portfolio features high-quality generic versions of essential medicines for hypertension, diabetes, and hyperlipidemia. Winsunny maintains advanced manufacturing bases in Beijing that adhere to national GMP standards. The company plays a significant role in the Chinese healthcare system by providing affordable and reliable treatments for large patient populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Winsunny Pharmaceutical.